188 related articles for article (PubMed ID: 26571361)
1. Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression.
Yabumoto C; Akazawa H; Yamamoto R; Yano M; Kudo-Sakamoto Y; Sumida T; Kamo T; Yagi H; Shimizu Y; Saga-Kamo A; Naito AT; Oka T; Lee JK; Suzuki J; Sakata Y; Uejima E; Komuro I
Sci Rep; 2015 Sep; 5():14453. PubMed ID: 26571361
[TBL] [Abstract][Full Text] [Related]
2. Resistance training prevents muscle fibrosis and atrophy via down-regulation of C1q-induced Wnt signaling in senescent mice.
Horii N; Uchida M; Hasegawa N; Fujie S; Oyanagi E; Yano H; Hashimoto T; Iemitsu M
FASEB J; 2018 Jul; 32(7):3547-3559. PubMed ID: 29401629
[TBL] [Abstract][Full Text] [Related]
3. Influences of AT1 receptor blockade on tissue metabolism in obese men.
Boschmann M; Engeli S; Adams F; Franke G; Luft FC; Sharma AM; Jordan J
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R219-23. PubMed ID: 16109807
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-Catenin Signaling Contributes to Skeletal Myopathy in Heart Failure via Direct Interaction With Forkhead Box O.
Okada K; Naito AT; Higo T; Nakagawa A; Shibamoto M; Sakai T; Hashimoto A; Kuramoto Y; Sumida T; Nomura S; Ito M; Yamaguchi T; Oka T; Akazawa H; Lee JK; Morimoto S; Sakata Y; Shiojima I; Komuro I
Circ Heart Fail; 2015 Jul; 8(4):799-808. PubMed ID: 26038536
[TBL] [Abstract][Full Text] [Related]
5. Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells.
Kobayashi T; Akiyama Y; Akiyama N; Katoh H; Yamamoto S; Funatsuki K; Yanagimoto T; Notoya M; Asakura K; Shinosaki T; Hanasaki K
Eur J Pharmacol; 2010 Dec; 649(1-3):23-8. PubMed ID: 20826135
[TBL] [Abstract][Full Text] [Related]
6. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.
Candido R; Allen TJ; Lassila M; Cao Z; Thallas V; Cooper ME; Jandeleit-Dahm KA
Circulation; 2004 Mar; 109(12):1536-42. PubMed ID: 15023892
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Dalla Libera L; Ravara B; Angelini A; Rossini K; Sandri M; Thiene G; Battista Ambrosio G; Vescovo G
Circulation; 2001 May; 103(17):2195-200. PubMed ID: 11331262
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury.
Hwang OK; Park JK; Lee EJ; Lee EM; Kim AY; Jeong KS
Int J Mol Sci; 2016 Feb; 17(2):227. PubMed ID: 26867195
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
10. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle.
Bedair HS; Karthikeyan T; Quintero A; Li Y; Huard J
Am J Sports Med; 2008 Aug; 36(8):1548-54. PubMed ID: 18550776
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of complement C1q reflects mucosal regeneration in a mouse model of colitis.
Gunji N; Katakura K; Abe K; Kawashima K; Fujiwara T; Onizawa M; Takahashi A; Ohira H
Med Mol Morphol; 2021 Jun; 54(2):87-94. PubMed ID: 33029672
[TBL] [Abstract][Full Text] [Related]
15. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes.
Naito AT; Sumida T; Nomura S; Liu ML; Higo T; Nakagawa A; Okada K; Sakai T; Hashimoto A; Hara Y; Shimizu I; Zhu W; Toko H; Katada A; Akazawa H; Oka T; Lee JK; Minamino T; Nagai T; Walsh K; Kikuchi A; Matsumoto M; Botto M; Shiojima I; Komuro I
Cell; 2012 Jun; 149(6):1298-313. PubMed ID: 22682250
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
[TBL] [Abstract][Full Text] [Related]
17. Irbesartan-mediated AT1 receptor blockade attenuates hyposmotic-induced enhancement of I Ks current and prevents shortening of action potential duration in atrial myocytes.
Wu J; Ding WG; Zhao J; Zang WJ; Matsuura H; Horie M
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):341-7. PubMed ID: 23386284
[TBL] [Abstract][Full Text] [Related]
18. Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats.
Sloniger JA; Saengsirisuwan V; Diehl CJ; Kim JS; Henriksen EJ
Metabolism; 2005 Dec; 54(12):1659-68. PubMed ID: 16311101
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
20. Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat.
Lou M; Blume A; Zhao Y; Gohlke P; Deuschl G; Herdegen T; Culman J
J Cereb Blood Flow Metab; 2004 May; 24(5):536-47. PubMed ID: 15129186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
